Inhibition by fenamates of calcium influx and proliferation of human lymphocytes

British Journal of Pharmacology

Volumn 119, Issue 3, 1996, Pages 487-494

  Kankaanranta, H ^a   Luomala, M ^b   Kosonen, O ^b   Moilanen, E ^b  

^a TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

^b NONE

Author keywords

Calcium; Cellular proliferation; Flufenamic acid; Lymphocytes; Mitogens; Non steroidal anti inflammatory drugs; Second messengers; Tolfenamic acid

Indexed keywords

CALCIUM ION; CONCANAVALIN A; FLUFENAMIC ACID; NONSTEROID ANTIINFLAMMATORY AGENT; PHORBOL 13 ACETATE 12 MYRISTATE; THAPSIGARGIN; TOLFENAMIC ACID;

ARTICLE; CALCIUM CELL LEVEL; CALCIUM TRANSPORT; HUMAN; HUMAN CELL; LYMPHOCYTE ACTIVATION; LYMPHOCYTE PROLIFERATION; MONONUCLEAR CELL; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL;

EID: 0029809389     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1476-5381.1996.tb15698.x     Document Type: Article

References (49)

1. ABRAMSON, S.B. (1992). Treatment of gout and crystal arthropathies and uses and mechanisms of action of nonsteroidal anti-inflammatory drugs. Curr. Opin. Rheumatol., 4, 295-300.
2. 2+ influx across the plasma membrane of human neutrophils. Mol. Pharmacol., 30, 437-443.
3. BAUERLE, P.A. & HENKEL, T. (1994). Function and activation of NF-κB in the immune system. Annu. Rev. Immunol., 12, 141-179.
4. BENZAQUEN, L.R., BRUGNARA, C., BYERS, H.R., GATTONI-CELLI, S. & HALPERIN, J.A. (1995). Clotrimazole inhibits cell proliferation in vitro and in vivo. Nature Med., 1, 534-540.
5. BIERER, B.E., HOLLÄNDER, G., FRUMAN, D. & BURAKOFF, S.J. (1993). Cyclosporin A and FK506: molecular mechanisms of immunosuppression and probes for transplantation biology. Curr. Opin. Immunol., 5, 763-773.
6. BØYUM, A. (1976). Isolation of lymphocytes, granulocytes and macrophages. Scand. J. Immunol., 5 (suppl), 9-15.
7. BROOKS, P.M. & DAY, R.O. (1991). Nonsteroidal antiinflammatory drugs-differences and similarities. N. Engl. J. Med., 324, 1716-1725.
8. CARDENAS, M.E. & HEITMAN, J. (1995). Role of calcium in T-lymphocyte activation. In Advances in Second Messenger and Phosphoprotein Research. Vol. 30. ed. Means, A.R., pp. 281-298. New York: Raven Press, Ltd.
9. 2 effect on T lymphocyte activation. J. Clin. Invest., 80, 333-340.
10. 2+ current, IL-2 production and activation in T lymphocytes. Br. J. Pharmacol., 113, 861-868.
11. CRABTREE, G.R. (1989). Contingent regulatory events in T lymphocyte activation. Science, 243, 355-361.
12. FANGER, C.M., HOTH, M., CRABTREE, G.R. & LEWIS, R.S. (1995). Characterization of T cell mutants with defects in capacitative calcium entry: genetic evidence for the physiological roles of CRAC channels. J. Cell Biol., 131, 655-667.
13. FLESCHER, E., FOSSUM, D., GRAY, P.J., FERNANDES, G., HARPER, M.J.K. & TALAL, N. (1991). Aspirin-like drugs prime human T cells. J. Immunol., 146, 2553-2559.
14. GALLIN, E.K. (1991). Ion channels in leukocytes. Physiol. Rev., 71, 775-811.
15. GALLIN, E.K. & GRINSTEIN, S. (1992). Ion channels and carriers in leukocytes. In Inflammation: Basic Principles and Clinical Correlates. ed. Gallin, J.I., Goldstein, I.M. & Snyderman, R. pp. 441-458. New York: Raven Press, Ltd.
16. GARDNER, P. (1989). Calcium and T lymphocyte activation. Cell, 59, 15-20.
17. GÖGELEIN, H., DAHLEM, D. ENGLERT, H.C. & LANG, H.J. (1990). Flufenamic acid, mefenamic acid and niflumic acid inhibit single nonselective cation channels in the rat exocrine pancreas. FEBS Lett., 268, 79-82.
18. GREENWOOD, I.A. & LARGE, W.A. (1995). Comparison of the effects of fenamates on Ca-activated chloride and potassium currents in rabbit portal vein smooth muscle cells. Br. J. Pharmacol., 116, 2939-2948.
19. 2+ indicators with greatly improved fluorescence properties. J. Biol. Chem., 260, 3440-3450.
20. HUPE, D.J., BOLTZ, R., COHEN, C.J., FELIX, J., HAM, E., MILLER, D., SODERMAN, D. & SKIVER, D.V. (1991). The inhibition of receptor-mediated and voltage-dependent calcium entry by the antiproliferative L-651, 582. J. Biol. Chem., 266, 10136-10142.
21. JUNG, F., SELVARAJ, S. & GARGUS, J.J. (1992). Blockers of platelet-derived growth factor-activated nonselective cation channel inhibit cell proliferation. Am. J. Physiol., 262, C1464-C1470.
22. KANKAANRANTA, H. & MOILANEN, K. (1995). Flufenamic and tolfenamic acids inhibit calcium influx in human polymorphonuclear leukocytes. Mol. Pharmacol., 47, 1006-1013.
23. KANKAANRANTA, H., MOILANEN, E. & VAPAATALO, H. (1994). Effects of non-steroidal anti-inflammatory drugs on polymorphonuclear leukocyte functions in vitro: focus on fenamates. Naunyn-Schmiedeberg's Arch. Pharmacol., 350, 685-691.
24. 2+ influx. Eur. J. Pharmacol., 291, 17-25.
25. KUNO, M. & GARDNER, P. (1987). Ion channels activated by inositol 1,4,5-trisphosphate in plasma membrane of human T-lymphocyles. Nature, 326, 301-304.
26. KUNO, M., GORONZY, J., WEYAND, C.M. & GARDNER, P. (1986). Single-channel and whole-cell recordings of mitogen-regulated inward currents in human cloned helper T lymphocytes. Nature, 323, 269-272.
27. 2+ current in human leukemic T cells. Cell Regul., 1, 99-112.
28. LEWIS, R.S. & CAHALAN, M.D. (1995). Potassium and calcium channels in lymphocytes. Annu. Rev. Immunol., 13, 623-653.
29. LIU, J. (1993). FK506 and ciclosporin: molecular probes for studying intracellular signal transduction. Trends Pharmucol. Sci., 14, 182-188.
30. LU, K.P. & MEANS, A.R. (1993). Regulation of the cell cycle by calcium and calmodulin. Endocrine Rev., 14, 40-58.
31. MCDONALD, T.V. PREMACK, B.A. & GARDNER, P. (1993). Flash photolysis of caged inositol 1,4,5-trisphosphate activates plasma membrane calcium current in human T cells. J. Biol. Chem., 268, 3889-3896.
32. MCLEAN, J.R. & GLUCKMAN, M.I. (1983). On the mechanism of the pharmacologic activity of meclofenamate sodium. Arzneim.-Forsch., 33, 627-631.
33. MEANS, A.R. (1994). Calcium, calmodulin and cell cycle regulation. FEBS Lett., 347, 1-4.
34. MERRITT, J.E., ARMSTRONG, W.P., BENHAM, C.D., HALLAM, T.J., JACOB, R., JAXA-CHAMIEC, A., LEIGH, B.K., MCCARTHY, S.A., MOORES, K.E. & RINK, T.J. (1990). SK&F 96365, a novel inhibitor of receptor-mediated calcium entry. Biochem. J., 271, 515-522.
35. MOILANEN, E. & KANKAANRANTA, H. (1994). Tolfenamic acid and leukotriene synthesis inhibition. Pharmacol. Toxicol., 75 (Suppl II), 60-63.
36. NORDSTRÖM, T., NEVANLINNA, H.A. & ANDERSSON, L.C. (1992). Mitosis-arresting effect of the calcium channel inhibitor SK&F 96365 on human leukemia cells. Exp. Cell. Res., 202, 487-494.
37. PEREZ, H.D., ELFMAN, H. & MARDER, S. (1987). Meclofenamate sodium monohydrate inhibits chemotactic factor-induced human polymorphonuclear leukocyte function. Arthritis Rheum., 30, 1023-1031.
38. 2+-ATPase inhibitors. J. Immunol., 152, 5226-5240.
39. PUTNEY, J.W. JR. (1990). Capacitative calcium entry revisited. Cell Calcium, 11, 611-624.
40. REJHOLEC, V., VAPAATALO, H., TOKOLA, O. & GOTHONI, G. (1979). Tolfenamic acid in the treatment of rheumatoid arthritis. Scand. J. Rheumatol., suppl. 24, 9-12.
41. REJHOLEC, V., VAPAATALO, H., TOKOLA, O. & GOTHONI, G. (1980). Tolfenamic acid in ankylosing spondylarthritis: a double-blind comparison to indomethacin. Scand. J. Rheumatol., suppl. 36, 3-7.
42. 2+ and proliferation of human lymphocytes in relation to AIDS. Biochim. Biophys. Acta, 972, 257-264.
43. SZAMEL, M. & RESCH, K. (1995). T-cell antigen receptor-induced signal-transduction pathways. Activation and function of protein kinases C in T lymphocytes. Eur. J. Biochem., 228, 1-15.
44. 2+-ATPase. Proc. Natl. Acad. Sci. U.S.A., 87, 2466-2470.
45. VEYES, H.M. (1991). 20 Year's experience with ketoprofen. Scand. J. Rheumatol., 20 (suppl. 90), 3-44.
46. VON TSCHARNER, V., PROD'HOM, B., BAGGIOLINI, M. & REUTER, H. (1986). Ion channels in human neutrophils activated by a rise in free cytosolic calcium concentration. Nature, 324, 369-372.
47. WALDMANN, T.A. (1993). The IL-2/IL-2 receptor system: a target for rational immune intervention. Trends Pharmacol. Sci., 14, 159-164.
48. WHITAKER, M (1995). Regulation of the cell division cycle by inositol trisphosphate and the calcium signaling pathway. In Advances in Second Messenger and Phosphoprotein Research. Vol. 30. ed. Means, A.R. pp. 299-310. New York: Raven Press, Ltd.
49. 2+ stores. Proc. Natl. Acad. Sci. U.S.A, 90, 6295-6299.